Melatonin receptors in PC3 human prostate tumor cells

Journal of Pineal Research

Volumn 26, Issue 4, 1999, Pages 211-220

  Gilad, Eli ^a   Laufer, Menachem ^b   Matzkin, Haim ^b   Zisapel, Nava ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Cancer; Cell density; Melatonin; PC3; Prostate

Indexed keywords

CHOLERA TOXIN; CYCLIC AMP; CYCLIC GMP; MELATONIN; MELATONIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

BINDING SITES; CELL COUNT; CELL SURVIVAL; CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; DNA; HUMANS; ISOQUINOLINES; MALE; MELATONIN; PERTUSSIS TOXIN; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SULFONAMIDES; THYMIDINE; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0032913883     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1999.tb00586.x     Document Type: Article

References (31)

1. ABDUL, M., P.E. ANEZINIS, C.J. LOGOTHETIS, N.M. HOOSEIN (1994) Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res. 14:1215-1220.
2. BANG, Y.J., S.J. KIM, D. DANIELPOUR, M.A. O'REILLY, K.Y. KIM, C.E. MYERS, J.B. TREPEL (1992) Cyclic AMP induced transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC3. Proc Natl Acad Sci USA 89:3556-3560.
3. BUBIS, M., Y. ANIS, N. ZISAPEL (1996) Enhancement by melatonin of GTP exchange and ADP ribosylation reactions. Mol. Cell. Endocrinol. 123:139-148.
4. BUBIS, M., N. ZISAPEL (1995a) Modulation by melatonin of protein secretion from melanoma cells: Is cAMP involved? Mol. Cell. Endocrinol. 112:169-175.
5. BUBIS, M., N. ZISAPEL (1995b) Facilitation and inhibition of G protein regulated protein secretion by melatonin. Neurochem. Int. 27:177-183.
6. BUBIS, M., N. ZISAPEL (1998) A role for NAD + and cADP-ribose in melatonin signal transduction. Mol. Cell Endocrinol. 137:59-67.
7. BUZZELL, G.R. (1988) Study on the effects of the pineal hormone melatonin on an androgen-insensitive rat prostatic adenocarcinoma, the Dunning R 3327 HIF tumor. J. Neural Trans. 72:131-140.
8. FAILLACE, M.P., M.I. KELLER SARMIENTO, R.E. ROSENSTEIN (1996) Melatonin effect on the cGMP system in the golden hamster retina. Brain Res. 711:112-117.
9. GILAD, E., M. LAUDON, H. MATZKIN, E. PICK, M. SOFER, Z. BRAF, N. ZISAPEL (1996) Functional melatonin receptors in human prostate epithelial cells. Endocrinology 137:1412-1417.
10. GILAD, E., H. MATZKIN, N. ZISAPEL (1997a) Inactivation of melatonin receptors by protein kinase C in human prostate epithelial cells. Endocrinology 138:4255-4261.
11. GILAD, E., E. PICK, H. MATZKIN, N. ZISAPEL (1997b) Melatonin receptors in benign prostate epithelial cells: Evidence for the involvement of cholera and pertussis toxins-sensitive G proteins in their signal transduction pathways. Prostate 159:1069-1073.
12. HILL, S.H., D.E. BLASK (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:6121-6126.
13. JOCKERS, R., L. PETIT, I. LACROIX, P. DECOPPET, F. BARRETT, P.J. MORGAN, B. GUARDIOLA, P. DELAGRANGE, S. MARULLO, A.D. STROSBERG (1997) Novel isoforms of Mellc melatonin receptors modulating intracellular cyclic guanosine 3′-5′-monophosphate levels. Mol. Endocrinol. 11:1070-1081.
14. KANO, T., Y. MIYACHI (1976) Direct action of melatonin on testosterone and cGMP production using rat testis tissue in vitro. Biochem. Biophys. Res. Commun. 72:969-975.
15. KHATTREE, H.C., S. DINDA, P. ALBAN, V.K. MOUDGVIL (1997) Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene 15:991-995.
16. KIMURA, M., M. OGIHARA (1998) Expression of alpha-2 and beta-2 adrenergic responses by hepatocyte growth factor and platelet derived growth factor in primary cultures of adult rat hepatocytes. Biol. Pharm. Bull. 21:22-28.
17. LAUDON, M., E. GILAD, H. MATZKIN, Z. BRAF, N. ZISAPEL (1996) Putative melatonin receptors in benign human prostate tissue. J. Clin. Endocrinol. Metab. 81:1336-1342.
18. LISSONI, P., M. CAZZANIGA, G. TANCINI, E. SCARDINO, R. MUSCI, S. BARNI, M. MAFFEZZINI, T. MERONI, F. ROCCO, A. CONTI, G. MAESTRONI (1997) Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: Efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone. Eur. Urol. 31:178-181.
19. MARKWELL, M.A.K., S.M. HAAS, L.C. BIEBER, N.E. TALBERT (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
20. MORGAN, P.J., B. PERRY, D. HAZLERIGG, G. MILLIGAN, W. LAWSON, A. MACLEAN, G. DAVIDSON (1995) Melatonin receptors couple through a cholera toxin-sensitive mechanism to inhibit cyclic AMP in ovine pituitary. J. Neuroendocrinol. 7:361-369.
21. OKUTANI, T., N. NISMI, Y, KAGAWA, H. TAKASUGA, I TAKENAKA, T. USUI, F, WADA (1991) Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells. Prostate 18:73-80.
22. PHILO, R., A.S. BERKOWITZ (1988) Inhibition of Dunning tumor growth by melatonin. J. Urol. 139:1099-1102.
23. Pozo, D., R.J. RETTER, J.R. CALVO, J.M GUERRERO (1997) Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65:430-442.
24. RETTER, R.J. (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocrine Rev. 12:151-180.
25. REPPERT, M., D.M. WEAVER, C. GODSON (1996) Melatonin receptors step into the light: Cloning and classification of subtypes. Trends Pharmacol. Sci. 17:100-102.
26. SORCI, G., A. SPRECA, R, DONATO, M.G. RAMBOTTI (1995) Detection of membrane-bound guanylate cyclase activity in rat C6 glioma cells at different growth states following activation by natriuretic pcptides. Brain Res 683:51-58.
27. STEINER, M.S., G.S. WAND, E.R. BARRACK (1995) Effects of transforming growth factor beta-1 on the adenylyl cyclase-cAMP pathway in prostate cancer. Growth Factors 11:283-290.
28. VACAS, M.I., M.I. SARMIENTO, D.P. CARDINALI (1981) Melatonin increases cGMP and decreases cAMP levels in rat medial basal hypothalamus in vitro. Brain Res. 225:207-211.
29. VAKKURI, O., J. LEPPALUOTO, O. VUOLTEENAHO (1984) Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin tracer. Acta Endocrinol. 106:152-157.
30. VANECEK, J., L. VOLLRATH (1989) Melatonin inhibits cAMP and cGMP accumulation in the rat pituitary. Brain Res. 505:157-159.
31. YANG, W., J. ANDO, R. KORENAGA, T. TOYO-OKA, A. KAMIYA (1994) Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commun. 203:1160-1167.